US 8,075,885 B2Granted

Methods of treating heart failure using an anti-GM-CSF antibody

AssigneeKaloBios Pharmaceuticals, Inc.

InventorsChristopher R. Bebbington, Geoffrey T. Yarranton

Life of this patent

Estimating the term…

Abstract

This invention relates to methods of treating a patient suffering from heart failure, or a patient at risk for heart failure, using a GM-CSF antagonist.

Claims28

Dependent claims

A method for treating a patient that has heart failure, the method comprising administering a therapeutically effective amount of a granulocyte macrophage colony stimulating factor (GM-CSF) antagonist to the patient, wherein the antagonist is an anti-GM-CSF antibody.

Dependencies are inferred from the claim text.

Facts

Application: 12/419,991Filed 7 Apr 2009 · us provisional application
Priority: 7 Apr 2008
Published: US 2009/0263387 A122 Oct 2009
Granted: 13 Dec 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification15 codes

C07K 16/243
Against cytokines, lymphokines or interferons: colony Stimulating Factors
A61K 38/1793
Receptors; Cell surface antigens; Cell surface determinants: for cytokines; for lymphokines; for interferons
A61K 38/39
From animals; from humans: connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
A61P 9/04
Drugs for disorders of the cardiovascular system: inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Family

Application61/043,026Us provisional application · filed 7 Apr 2008
US 2009/0263387 A1Pre-grant publication · published 22 Oct 2009
US 8,075,885 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results